Hledání v detailu akcií
Moje portfolio
Nastavit Oblíbené, nastavit Portfolio
Oblíbené tituly
select
NázevNejlepší
nákup
Nejlepší
prodej
Změna
(%)
ČEZ570,5571,50,00
KB901,5902,5-0,11
PKN99,1499,261,54
Msft113,61114,040,00
Nokia4,6954,7-0,72
IBM149,85151,320,00
Daimler AG56,8856,9-1,25
PFE43,1143,90,00
24.9.2018 11:05:59
Indexy online
AD Index online
select
AD Index online
 

  • 21.9.2018
Inogen (NASDAQ Cons)
Závěr k 21.9.2018 Změna (%) Změna (USD) Objem obchodů (ks)
254,70 0,28 0,70 323 171
Premarket24.9.2018 10:00:00
Poslední obchod Nákup / Prodej Změna (%) Změna (USD) Objem obchodů (ks)
- 223,22 273,00 - - -
R - Real-Time data si mohou aktivovat klienti Patria Plus / Investor Plus ZDE.

 
  • Poslední aktualizace: 24.9.2018
Popis společnosti
Obecné informace
Název společnostiInogen Inc
TickerINGN
Kmenové akcie:Ordinary Shares
RICINGN.O
ISINUS45780L1044
Poslední známé roční výsledky31.12.2017
Poslední známé čtvrtletní výsledky30.6.2018
Počet zaměstnanců k 31.12.2017 770
Akcie v oběhu k 31.7.2018 21 350 470
Počet akcionářů k 31.12.2017 16
MěnaUSD
Konstituent indexůS&P 600 Small Cap
Kontaktní informace
Ulice326 Bollay Dr
MěstoGOLETA
PSČ93117-5550
ZeměUnited States
Kontatní osoba 
Funkce kontaktní osoby 
Telefon18 055 620 500
Fax13026365454

Business Summary: Inogen, Inc. is a medical technology company. The Company develops, manufactures and markets portable oxygen concentrators used to deliver supplemental long-term oxygen therapy to patients suffering from chronic respiratory conditions. The Company's Inogen One systems concentrate the air around the patient to offer a single source of supplemental oxygen anytime, anywhere with a portable device. Its three portable product offerings, the Inogen One G4, Inogen One G3 and Inogen One G2, at approximately 2.8, 4.8 and 7.0 pounds with a single battery, respectively. Its Inogen One G4, Inogen One G3 and Inogen One G2 are sub-3, sub-5 and sub-10 pound portable oxygen concentrators, respectively. All of its Inogen One systems are equipped with Intelligent Delivery Technology. The Inogen At Home stationary oxygen concentrator allows it to access the non-ambulatory oxygen patient market and serves as a backup to its Inogen One system for ambulatory patients on its rental service.
Financial Summary: BRIEF: For the six months ended 30 June 2018, Inogen Inc revenues increased 51% to $176.3M. Net income increased 78% to $25.4M. Revenues reflect Sales revenue increase of 59% to $165.6M. Net income benefited from Interest Income increase from $247K to $1.2M (income). Basic Earnings per Share excluding Extraordinary Items increased from $0.69 to $1.20.
Odvětvová klasifikace
TRBC2009Medical Equipment / Supplies / Distribution
TRBC2012Medical Equipment, Supplies & Distribution - NEC
RBSS2004Medical Equipment, Supplies & Distribution
MGINDUSTRYMedical Equipment & Supplies
MGSECTORHealthcare
NAICSElectromedical and Electrotherapeutic Apparatus Manufacturing
NAICSSurgical and Medical Instrument Manufacturing
SICElectromedical Equipment
SICSurgical And Medical Instruments



  • Poslední aktualizace: 24.9.2018
Management společnosti
FunkceJménoVěkVe funkci odVe firmě od
Independent Chairman of the BoardHeath Lukatch511.1.2008
President, Chief Executive Officer, DirectorScott Wilkinson531.3.20171.1.2008
Executive Vice President - Finance and Chief Financial Officer, Corporate Secretary and Corporate TreasurerAlison Bauerlein36
Executive Vice President of Sales and MarketingByron Myers381.1.20171.1.2011
Executive Vice President - OperationsMatthew Scribner50
Executive Vice President - EngineeringBrenton Taylor36